Intestinal Symptoms and Manifestations of FIP
Feline Infectious Peritonitis (FIP) is a complex, often fatal disease caused by a mutated form of feline coronavirus. While FIP is primarily associated with systemic and neurological symptoms, gastrointestinal and intestinal manifestations are also significant and can complicate diagnosis. Recognizing these symptoms early is crucial for veterinary professionals to improve management and outcome. The intestinal signs of FIP are often subtle yet can mimic other gastrointestinal disorders, complicating clinical assessments.
Gastrointestinal Clinical Signs
The most common intestinal symptoms in FIP include diarrhea, inappetence, and weight loss. Diarrhea may be intermittent or persistent, often accompanied by fecal mucus or blood, reflecting underlying inflammation or vasculitis in the intestinal walls. Loss of appetite usually results from nausea, discomfort, or systemic illness, leading to progressive weight depletion. These signs frequently overlap with other gastrointestinal conditions such as inflammatory bowel disease (IBD) or parasitic infections, necessitating thorough diagnostic evaluation.
Vomiting and Abdominal Discomfort
Vomiting is a frequent presenting symptom associated with intestinal involvement. It can be episodic or persistent, often linked to nausea or gastric ileus secondary to intestinal inflammation. Additionally, cats may exhibit signs of abdominal pain, such as vocalization when the abdomen is palpated, tense abdomen, or reluctance to be handled. This discomfort often correlates with vasculitis-induced edema and infiltration of inflammatory cells in the intestinal muscular layers and mesenteric vessels. Abdominal distension may also be observed in some cases, indicative of ascites or edema.
Altered Bowel Movements and Changed Faecal Characteristics
Apart from diarrhea, some cats may develop constipation or changes in fecal consistency due to malabsorption or infiltration of inflammatory cells into the gut wall. FIP-associated gastrointestinal lesions often result in disrupted mucosal architecture, impairing nutrient absorption and water regulation, which manifests as variable stool patterns. Moreover, fecal mucus, melena, or hematochezia can be observed, further complicating the clinical picture.
Laboratory and Diagnostic Features
Blood analyses often reveal anemia, hypoalbuminemia, and hyperglobulinemia, reflecting systemic inflammatory and immune responses. Elevated serum amyloid A and other acute-phase proteins might suggest ongoing inflammation. Radiographs and ultrasonography typically show thickening of the intestinal walls, especially in the small intestine, with fine hyperechoic enhancements or multifocal hypoechoic lesions. Abdominal ultrasound may reveal mesenteric lymphadenopathy and ascites, often straw-colored in FIP cases. Cytological examination of effusions can reveal immune complex deposition, while biopsies frequently demonstrate vasculitis, granulomatous inflammation, and infiltration of mononuclear cells within the intestinal mucosa.
Pathogenesis of Intestinal Manifestations
The intestinal manifestations of FIP mainly result from vasculitis—a hallmark feature—leading to increased vascular permeability, edema, and hemorrhage within the intestinal wall. The immune-mediated response against the mutated coronavirus induces widespread vascular damage, resulting in ischemia and subsequent mucosal damage. Granulomatous lesions and fibrinonecrotic inflammation compromise intestinal integrity, contributing to clinical signs such as diarrhea, bleeding, and pain.
Differential Diagnosis and Challenges
Distinguishing FIP-associated intestinal disease from other enteric disorders is challenging. Conditions like inflammatory bowel disease, lymphoma, parasitism, and bacterial infections share overlapping clinical signs. Moreover, definitive diagnosis requires invasive procedures such as biopsies, which may be risky in compromised cats. Serological testing for coronavirus antibodies cannot distinguish between benign enteric infection and FIP-causing mutated strains. Consequently, clinicians often rely on a combination of clinical signs, laboratory findings, imaging, and sometimes post-mortem examination to confirm the diagnosis.
Unique Aspects and Emerging Insights
Recent research highlights the role of immune pathways, especially the balance between cell-mediated and humoral immunity, in the development of intestinal FIP lesions. Novel diagnostic tools, such as RT-PCR assays targeting mutated viral strains and immunohistochemistry, have improved accuracy. Emerging studies suggest that early intervention with immunomodulatory agents may alter disease progression, particularly in cases with prominent intestinal signs. Understanding the molecular and immunological mechanisms driving gastrointestinal involvement offers potential for targeted therapies, minimizing systemic spread and local tissue damage.
References
1. Pedersen, N. C. (2014). Feline Infectious Peritonitis: Making and Breaking the Disease. Journal of Feline Medicine and Surgery, 16(3), 185–192.
2. Kipar, A., & Meli, M. L. (2014). Feline Infectious Peritonitis: Still an Enigmatic Disease. Journal of Feline Medicine and Surgery, 16(12), 1053–1064.
3. Addie, D. D., et al. (2014). Feline Coronavirus Infection. Veterinary Microbiology, 177(1), 10–21.
4. Kipar, A., et al. (2015). Pathogenesis of feline infectious peritonitis. Veterinary Immunology and Immunopathology, 169(1–2), 42–53.
5. Schatzberg, S. J., & Addie, D. D. (2018). Feline Infectious Peritonitis. In In Practice, 40(7), 302–308.
